ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours

Rodney J. Hicks, Clarisse Dromain, Wouter W. de Herder, Frederico P. Costa, Christophe M. Deroose, Andrea Frilling, Anna Koumarianou, Eric P. Krenning, Eric Raymond, Lisa Bodei, Halfdan Sorbye, Staffan Welin, Bertram Wiedenmann, Damian Wild, James R. Howe, James Yao, Dermot O’Toole, Anders Sundin, Vikas Prasad

Research output: Contribution to journalArticlepeer-review

10 Scopus citations


The European Neuroendocrine Tumor Society (ENETS) promotes practices and procedures that aim to improve the standard of care delivered to patients diagnosed with or suspected of having neuroendocrine neoplasia (NEN). At its annual Scientific Advisory Board Meeting in 2018, experts in imaging, pathology and clinical care of patients with NEN drafted guidance for the standardised reporting of diagnostic studies critical to the diagnosis, grading, staging and treatment of NEN. These included pathology, radiology, endoscopy and molecular imaging procedures. In an iterative process, a synoptic reporting template for molecular imaging procedures was developed to guide personalised therapies. Following pilot implementation and refinement within the ENETS Center of Excellence network, harmonisation with specialist imaging societies including the Society of Nuclear Medicine, European Association of Nuclear Medicine and the International Cancer Imaging Society will be pursued.

Original languageEnglish
Article numbere13040
JournalJournal of Neuroendocrinology
Issue number3
StatePublished - Mar 2022


  • PET
  • neuroendocrine neoplasia
  • synoptic reporting


Dive into the research topics of 'ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours'. Together they form a unique fingerprint.

Cite this